Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Parkinson's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 41 articles: HTML format

Single Articles

February 2008
1. KONG XY , Cai Z, Pan L, Zhang L, et al
   Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. SINGH S , Singh K, Patel S, Patel DK, et al
   Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. KAARIAINEN TM , Piltonen M, Ossola B, Kekki H, et al
   Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. NEHRU B , Verma R, Khanna P, Sharma SK, et al
   Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
5. HASHIMOTO T , Nishi K, Nagasao J, Tsuji S, et al
   Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in dopaminergic neurons.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. AGARI T , Yasuhara T, Matsui T, Kuramoto S, et al
   Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: Behavioral and histological analyses.
   Brain Res. 2008;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
7. PARKER WD JR , Parks JK, Swerdlow RH
   Complex I deficiency in Parkinson's disease frontal cortex.
   Brain Res. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. VAN VLIETA SA , Blezer EL, Jongsma MJ, Vanwersch RA, et al
   Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
   Brain Res. 2007;.
   PubMed     Related articles    Abstract available
   
   
   October 2007
9. DARA C , Monetta L, Pell MD
   Vocal emotion processing in Parkinson's disease: Reduced sensitivity to negative emotions.
   Brain Res. 2007;.
   PubMed     Related articles    Abstract available
   
   
   September 2007
10. BLACKINTON JG , Anvret A, Beilina A, Olson L, et al
    Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. MILLER RL , Sun GY, Sun AY
    Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase.
    Brain Res. 2007;1167:129-39.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    August 2007
12. TASSORELLI C , Armentero MT, Greco R, Fancellu R, et al
    Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
13. DUPRE KB , Eskow KL, Negron G, Bishop C, et al
    The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Brain Res. 2007;1158:135-43.
    PubMed     Related articles    Abstract available
    
    
    May 2007
14. MATSUKAWA N , Maki M, Yasuhara T, Hara K, et al
    Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronicially 6-OHDA-lesioned Parkinsonian rats.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
15. HIGASHI S , Biskup S, West AB, Trinkaus D, et al
    Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
16. WILKINSON L , Jahanshahi M
    The striatum and probabilistic implicit sequence learning.
    Brain Res. 2007;1137:117-30.
    PubMed     Related articles    Abstract available
    
    
    February 2007
17. MALLOL R , Barros-Loscertales A, Lopez M, Belloch V, et al
    Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. MARCHIONINI DM , Lehrmann E, Chu Y, He B, et al
    Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. JANA S , Maiti AK, Bagh MB, Banerjee K, et al
    Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: Implications in Parkinson's disease.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
20. SCHMITT-ELIASSEN J , Ferstl R, Wiesner C, Deuschl G, et al
    Feedback-based versus observational classification learning in healthy aging and Parkinson's disease.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. TOBIN JE , Cui J, Wilk JB, Latourelle JC, et al
    Sepiapterin reductase expression is increased in Parkinson's disease brain tissue.
    Brain Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    December 2006
22. KREISLER A , Gele P, Wiart JF, Lhermitte M, et al
    Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
23. LIPINA SJ , Colombo JA
    Premorbid exercising in specific cognitive tasks prevents impairment of performance in parkinsonian monkeys.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
24. GARCIA-ARENCIBIA M , Gonzalez S, de Lago E, Ramos JA, et al
    Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
25. YE M , Wang XJ, Zhang YH, Lu GQ, et al
    Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
26. SEIDLER RD , Tuite P, Ashe J
    Selective impairments in implicit learning in Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
27. HONG M , Perlmutter JS, Earhart GM
    Podokinetic after-rotation in Parkinson disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
28. KALKONDE YV , Morgan WW, Sigala J, Maffi SK, et al
    Chemokines in the MPTP model of Parkinson's disease: Absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
29. DUVAL C , Sadikot AF, Panisset M
    Bradykinesia in patients with essential tremor.
    Brain Res. 2006;1115:213-6.
    PubMed     Related articles    Abstract available
    
    
    September 2006
30. FANG X , Sugiyama K, Akamine S, Namba H, et al
    Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
31. ICZKIEWICZ J , Jackson MJ, Smith LA, Rose S, et al
    Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
32. CANNON JR , Keep RF, Schallert T, Hua Y, et al
    Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
33. WITT K , Daniels C, Schmitt-Eliassen J, Kernbichler J, et al
    The impact of normal aging and Parkinson's disease on response preparation in task-switching behavior.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
34. SUON S , Yang M, Iacovitti L
    Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
35. WINOGRAD-GURVICH C , Georgiou-Karistianis N, Fitzgerald PB, Millist L, et al
    Self-paced saccades and saccades to oddball targets in Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
36. KOBAYASHI K , Yasuhara T, Agari T, Muraoka K, et al
    Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
37. DE MEIRA SANTOS LIMA M , Braga Reksidler A, Marques Zanata S, Bueno Machado H, et al
    Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
38. SCHNEIDER JS , Bradbury KA, Anada Y, Inokuchi JI, et al
    The synthetic ceramide analog l-PDMP partially protects striatal dopamine levels but does not promote dopamine neuron survival in murine models of parkinsonism.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    May 2006
39. ZHANG X , Andren PE, Svenningsson P
    Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
40. QUINTERO EM , Willis L, Singleton R, Harris N, et al
    Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease.
    Brain Res. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
41. DIETZ GP , Valbuena PC, Dietz B, Meuer K, et al
    Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease.
    Brain Res. 2006;1082:61-6.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: